Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MabVax Therapeutics Holdings Inc.

www.mabvax.com

Latest From MabVax Therapeutics Holdings Inc.

BioNTech Snaps Up Pancreatic Cancer Antibody, US Infrastructure

Europe’s largest private family-backed biotech adds to its antibody pipeline and its infrastructure in the US with assets from MabVax Therapeutics, in order to pioneer patient-specific immunotherapies for cancer and infections.

 

Deals ImmunoOncology

Finance Watch: Opko's Stock Halted As Nasdaq Awaits An Explanation For SEC Pump-And-Dump Lawsuit

Public Company Edition: An SEC complaint alleges that the company, Opko CEO Frost and co-defendants bought penny stocks, pumped up their value, then dumped shares for sizeable profits. Also, Pfizer and Retrophin float debt offerings, while Zealand sells royalties and milestone fees to raise cash.

Financing Regulation

Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera

AZ’s MedImmune to use 4D’s AAV vector technology to deliver therapies for chronic lung disease, while Roivant spinout Dermavant licenses Phase III-ready autoimmune candidate tapinarof from GSK.

Deals Commercial

Lilly Reacquires Aurora Kinase Inhibitor Via AurKa Buy For $110m

Many Aurora kinase inhibitors have entered development, but while none have had a successful end, Lilly believes the specificity of AurKa's AK-01 will make it a safer drug. The asset fits well into Lilly's oncology strategy, which includes both targeted therapies and immuno-oncology drugs.

Deals Cancer
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Alias(es)
  • Terrapin Diagnostics Inc.
  • Telik Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MabVax Therapeutics Holdings Inc.
  • Senior Management
  • J. David Hansen, Pres. & CEO
    Gregory P Hanson, CFO
    Philip Livingston, MD, CSO
    Paul Resnick, MD, VP, CBO
    Paul W Maffuid, PhDD, EVP, R&D
    Wolfgang W Scholz, PhD, VP, Antibody Discovery
  • Contact Info
  • MabVax Therapeutics Holdings Inc.
    Phone: (858) 259-9405
    11535 Sorrento Valley Rd.
    Ste. 400
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register